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Alcohol metabolism in vivo cannot be explained solely by the action of the classical alcohol dehydrogenase, Class I ADH (ADH1). Over the
past three decades, attempts to identify the metabolizing enzymes responsible for the ADH1-independent pathway have focused on the
microsomal ethanol oxidizing system (MEOS) and catalase, but have failed to clarify their roles in systemic alcohol metabolism. In this study, we
used Adh3-null mutant mice to demonstrate that Class III ADH (ADH3), a ubiquitous enzyme of ancient origin, contributes to alcohol metabolism
in vivo dose-dependently resulting in a diminution of acute alcohol intoxication. Although the ethanol oxidation activity of ADH3 in vitro is low
due to its very high Km, it was found to exhibit a markedly enhanced catalytic efficiency (kcat/Km) toward ethanol when the solution
hydrophobicity of the reaction medium was increased with a hydrophobic substance. Confocal laser scanning microscopy with Nile red as a
hydrophobic probe revealed a cytoplasmic solution of mouse liver cells to be much more hydrophobic than the buffer solution used for in vitro
experiments. So, the in vivo contribution of high-Km ADH3 to alcohol metabolism is likely to involve activation in a hydrophobic solution. Thus,
the present study demonstrated that ADH3 plays an important role in systemic ethanol metabolism at higher levels of blood ethanol through
activation by cytoplasmic solution hydrophobicity.
© 2005 Elsevier B.V. All rights reserved.Keywords: Alcohol metabolism; Class III ADH; Class I ADH; Knockout mouse; Activation by solution hydrophobicity; Acute alcohol intoxication1. Introduction
Alcohol dehydrogenase (ADH, EC 1.1.1.1) activity in the
liver is generally accepted to be the primary factor determining
the rate of alcohol metabolism in vivo [1]. However, some
aspects of the enzymatic pathways of alcohol metabolism are
still controversial, because the existence of another pathway
independent of ADH has also been demonstrated [2–4]. TheAbbreviations: ADH, alcohol dehydrogenase; Adh1 or Adh3, mouse Class I
or Class III ADH gene; Adh1−/− or Adh3−/−, disruption in Adh1 or Adh3; WT,
wild type; MEOS, microsomal ethanol oxidizing system; LORR, loss of righting
reflex; CNS, central nervous system
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doi:10.1016/j.bbadis.2005.11.008non-ADH pathway, which actually means a pathway indepen-
dent of Class I ADH (ADH1) [5], is known to be insensitive to
pyrazoles (specific inhibitors for ADH) [2] and to have a greater
metabolic role at high levels of blood alcohol [3]. Studies on
animals genetically lacking ADH1 have revealed that the
ADH1-independent pathway accounts for more than 30% of
total systemic alcohol metabolism [4,6]. Moreover, this
pathway is thought to play a major role in alcohol metabolism
in alcoholics, as well as in alcohol metabolism during acute
intoxication, because the activity of ADH1 in the liver decreases
markedly in both cases [7,8]. The identification of this pathway
has long been the subject of a sometimes-heated scientific
debate, the main question being whether the microsomal
ethanol oxidizing system (MEOS) [2,9–12] or catalase [13–
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has been assumed to have a greater role in alcohol metabolism
after chronic alcohol consumption due to enzyme induction [9].
However, it has recently been demonstrated that there is no
difference in the elimination rate of blood ethanol between
CYP2E1-null mice and wild-type mice, even after chronic
ethanol feeding [16]. The role of catalase has not been clarified
in vivo, either, even though mice genetically lacking catalase
have been reported [17]. Furthermore, the first-order kinetics of
the elimination of blood ethanol observed at very high
concentrations [18,19] suggests the involvement of some kind
of very high-Km enzyme in alcohol metabolism in vivo, since
the elimination kinetics cannot be explained by the Kms of
MEOS [9] and catalase [13]. Thus, the enzymatic nature of the
ADH1-independent pathway is still unclear.
Mammalian livers are known to contain two ADH
isozymes other than ADH1, i.e. ADH2 (Class II) and ADH3
(Class III) [5,20]. ADH2 has little contribution to the liver
ethanol activity of mouse, whereas ADH3 accounts for a
minor part of the activity with a very high Km for ethanol [8].
ADH3 is the most evolutionarily constant and ancestral form
among all the ADHs hitherto discovered, is present throughout
the biological world [21], and is expressed in all mammalian
tissues [22]. This housekeeping enzyme has been found to be
multifunctional: it plays important roles in formaldehyde
metabolism as a glutathione-dependent formaldehyde dehy-
drogenase [23], in NO metabolism as an S-nitrosoglutathione
reductase [24], and in the oxidation of retinol for the synthesis
of retinoic acid [25].
The role of ADH3 in systemic alcohol metabolism has
received little attention due to its very high Km for ethanol.
However, this ADH exhibits the greatest activity toward ethanol
at molar concentrations and is the most insensitive to pyrazoles
among all classes of ADHs [20]. In addition, its activity toward
ethanol at the concentrations found in blood is markedly
enhanced by a hydrophobic substance [26,27]. In the livers of
alcoholics, the activity of ADH3 increases as the total alcohol
intake rises, although that of ADH1 decreases [28]. Recent
studies have suggested that ADH3 participates in the first-pass
metabolism of ethanol through the stomach [29,30] and in
alcohol metabolism in pancreatic acinar cells [31]. These results
suggest a possible role of ADH3 in alcohol metabolism in vivo.
In the present study, we investigated the contribution of
ADH3 to systemic alcohol metabolism by comparing the
pharmacokinetics of blood ethanol in Adh3-null mutant mice to
that of wild-type mice. In addition, we examined the apparent
discrepancy between our finding of a significant role of ADH3
in ethanol metabolism in vivo and its poor activity toward
ethanol in vitro by studying the relationship between its activity
and the conditions of the reaction medium.
2. Materials and methods
2.1. Mouse genotypes
Mice carrying homozygous null mutations of Adh1 and Adh3 (Adh1−/−
and Adh3−/−) [6] were transferred to Nippon Medical School from the
Burnham Institute. Wild-type (WT) control mice were generated by mating theC57BL/6 (♀) and 129/Svj (♂) strains (Sankyo Lab, Tokyo) because Adh-null
mice are a 50:50 mixture of the two. All of these mice had the same genetic
background and were raised on a standard mouse diet (MF pellets, Oriental
Yeast Co., Ltd., Tokyo) in a SPF room for experimental animals. Both types of
Adh-null mice were apparently normal, except that Adh3−/− mice weighed
about 28% less than WT mice, as described previously [25]. All animals
received humane care in compliance with our institutional guidelines “The
Regulations on Animal Experimentation of the Nippon Medical School”,
which is based on “The Guidelines of the International Committee on
Laboratory Animals 1974”.
2.2. In vivo studies
2.2.1. Administration of ethanol to mice
Male mice (8–12 weeks old) were injected intraperitoneally with a 13.4,
20.1, 26.8, 30.2, or 33.5% (w/v) ethanol solution in physiological saline (15 μl/g
of body weight), resulting in an ethanol dose of 2.0, 3.0, 4.0, 4.5, or 5.0 g/kg,
respectively. Five mice of each genotype were given each dose, except for the
5.0-g/kg dose, for which 10 mice per genotype were used. The injection of
ethanol was performed between 9:00 and 11:00 a.m., and the treated mice were
subsequently provided only with water during the experiments.
2.2.2. Blood ethanol concentration and β value
Blood (10 μl) was periodically collected from the tail vein of a mouse
after the administration of ethanol and was immediately sealed in a vial
containing 1 ml of 0.0025% n-propanol in saline solution as an internal
standard. Blood ethanol concentration was measured with a head-space gas
chromatograph (Perkin-Elmer Head Space Analyzer 8500 with a fused silica
capillary column [PEG-20M; 3.0-μm film thickness, 25 m×0.53 mm bore,
Quadrex Corp. Conn.]) at an oven temperature of 60 °C and an injection
temperature of 150 °C using a flame ionization detector at 200 °C after
preincubation in a HS-6 head-space sampler at 65 °C for 30 min. The
elimination rate of blood ethanol (β value) was obtained from the slope of a
regression line fitted to the pseudo-linear part of a blood ethanol curve by the
linear least-squares method [32].
2.2.3. Loss of Righting Reflex (LORR) and mortality due to ethanol
administration
Ethanol-induced LORR was assessed by placing mice (n=5 for each dose of
ethanol) on their backs and measuring the time until the reflex recovered, as
described elsewhere [33]. The mortality of mice (n=10) was observed for 6
h after ethanol administration at doses of 4.5 and 5.0 g/kg.
2.3. In vitro analyses of ADH
The liver and stomach extracts of untreated mice of each genotype (9
weeks old, ♂) were obtained by centrifugation (105,000×g for 1 h at 2 °C)
after tissue homogenization in 6 volumes (w/v) of extraction buffer (10 mM
Tris–HCl, 0.5 mM NAD, pH 8.0) on ice. The electrophoresis of tissue extract
and the activity staining of ADH on the gel were performed as previously
described [34]. The ADH activity of liver extract was assayed in 0.1 M Na, K-
phosphate buffer (pH 7.4) at 37 °C with various concentrations of ethanol as a
substrate, and the production rate of NADH was monitored with a
fluorescence spectrophotometer (excitation at 350 nm, emission at 466 nm)
(FP-770F, Japan Spectroscopic Co., Tokyo) [27]. The effects of hydrophobic
substances on the ethanol oxidation activity of ADH3 were studied using
purified ADH3 prepared from WT-mouse liver, as described previously [34].
The protein concentration was determined using Coomassie protein assay
reagent (Pierce, Rockford, Ill).
2.4. Evaluation of cytoplasmic solution hydrophobicity of liver cells
The liver from a WT mouse (9 weeks old,♂) was washed, and sliced into
60-μm-thick sections in PBS on ice. The tissue was mounted on a micro slide
glass (Matsunami Glass IND. Co. Ltd., Osaka, Japan) and stained with 10 μl of
Nile red (40 μg/ml), which acts as a fluorescent probe of hydrophobicity [35].
The stained preparation was observed using a fluorescence microscope (BX50,
Fig. 1. Comparison of elimination rates of blood ethanol (β values) in Adh3−/−
mice (–●–) and WT mice (–○–) for various doses of ethanol (n=5 for each
dose). The difference in β value curves between Adh3−/− and WT mice were
significant (Pb0.005 by ANOVA), as was the interaction between genotype and
ethanol dose (Pb0.0001). –▪–: Adh1−/− mice.
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wavelengths of 480–700 nm through a dichroic mirror (DM455). For the same
sample, the emission fluorescence spectrum of Nile red was measured with a
photonic multichannel analyzer (PMA-11; Hamamatsu Photonics, Shizuoka,
Japan), installed on the fluorescence microscope [36]. The intensity of the
fluorescence spectrum for each specimen was normalized by adjusting the scale
of the y axis to place the maximum peak height at 1.0 on a full-chart scale. The
fluorescence intensity of unstained liver tissue was expressed as the ratio of its
peak height to that for stained liver tissue. In order to measure the spectrum for
cell membranes, a sample of cell ghosts was prepared by bursting mouse red
cells in distilled water and centrifuging them 3 times at 3000 rpm.
To further analyze the Nile red fluorescence of liver cells, the same sample
was observed using a confocal laser scanning microscope (CLSM-GB;
Olympus, Tokyo, Japan) with an argon laser at an excitation wavelength of
488 nm and a band-pass filter for emission wavelengths above 640 nm. A flame
scan was performed with 4× integration at a scanning speed of 512 lines/2 s
(1 scan comprised 515 pixels). An image was divided into 256 phases of
fluorescence intensity from black to white [36,37].
2.5. Statistics
The elimination curve of blood ethanol, the β value, and the duration of
LORR were tested by an analysis of variance (one or two-way ANOVA) for
mouse genotype, time, and ethanol dose using the standard statistics software
“Stat View, Version 4.5” (Abacus Concepts, Inc., NC). The interaction between
factors was also tested by two-way ANOVA. The β values of the two genotypes
were compared at each ethanol dose by Student's t test. Results were considered
statistically significant when Pb0.05.3. Results
3.1. Blood ethanol concentration and elimination rate in Adh-
null mice
The maximum concentrations of blood ethanol, Cmax, on an
average among the three genotypes of mice, reached about 40,
62, 87 or 91 mM for an ethanol dose of 2, 3, 4 or 4.5 g/kg,
respectively. Ethanol blood curves exhibited pseudo-linearity
from 1.0 to 3.0 h after ethanol administration for a 2.0 g/kg
dose; from 1.0 to 5.0 h for 3.0 g/kg; from 2.0 to 8.0 h for 4.0
g/kg; and from 2.0 to 10 h for 4.5 g/kg. The behavior of blood
ethanol concentration over time in Adh3−/− mice was
markedly different from that in WT mice for all doses of
ethanol tested in the range of 2.0–4.5 g/kg (Pb0.005–0.0001
by two-way ANOVA). The interaction between mouse
genotype and time was also seen at doses of 3.0, 4.0 and
4.5 g/kg (Pb0.005–0.0001).
Fig. 1 compares the β values for various doses of ethanol for
Adh3−/− andWTmice. The dose had a markedly different effect
on the β value in the two types of mice. Although the value
decreased dose-dependently in both types, it decreased more
sharply for Adh3−/− than for WT mice (Pb0.005 for genotype,
Pb0.0001 for the interaction between genotype and dose); and
the value for Adh3−/− mice was significantly lower than that for
WT mice at large doses of ethanol (Pb0.005–0.0001 for doses
of 3.0, 4 .0, and 4.5 g/kg by t test). The rate of ethanol
elimination from the body (mg/kg/h), which is given by the
ethanol dose divided by the elimination time of blood ethanol,
was also significantly lower for Adh3−/− mice than for WT mice
(Pb0.05 for genotype, Pb0.0001 for the interaction between
genotype and dose).As expected, Adh1−/− mice showed a significant difference
from WT mice in the behavior of blood ethanol concentration
over time and in the interaction between genotype and time at
every dose of ethanol (Pb0.0001). The β value for Adh1−/−
mice was the smallest among the three genotypes, and less
than one third the value for WT mice at every dose of ethanol
(Fig. 1).
3.2. Effect of ethanol on central nervous system of Adh-null
mice
We examined the effect of ethanol on the central nervous
system (CNS) of the three genotypes by measuring the duration
of LORR and mortality. The duration of LORR was
significantly longer in Adh3−/− than in WT mice for doses of
4, and 4.5 g/kg (Fig. 2) (Pb0.005 by two-way ANOVA). The
mortality at a dose of 5 g/kg was higher in Adh3−/− than in WT
mice (100% vs. 33.3%, n=10).
Among the three genotypes, the duration of LORR was the
longest for Adh1−/− mice. The time was 5.2 and 6.7 times
longer than that of WT mice at doses of 3 and 4 g/kg,
respectively. The mortality of Adh1−/− mice was 40% (n=5)
and 100% (n=10) at doses of 4.5 and 5.0 g/kg, respectively.
3.3. ADH isozymes of Adh-null mice
As shown in Fig. 3, the liver of WT mice possessed activity
bands for both ADH1 (Class I) and ADH3 (Class III), unlike the
livers of Adh3−/− and Adh1−/−mice, which were deficient in the
ADH3 and ADH1 bands, respectively. The ADH2 (Class II)
band was faintly seen in all three genotypes. The stomach of
Adh1−/− mice possessed both ADH3 and ADH4 (Class IV)
bands, while that of Adh3−/− mice was deficient in the ADH3
band.
The liver ADH of Adh3−/− mice exhibited lower activities
than that of WT mice at ethanol concentrations above 30 mM,
indicating the contribution of ADH3 to the liver ethanol
Fig. 4. Liver ADH activities of Adh3−/− (–●–), Adh1−/− (–▪–) and WT (–○–)
mice at various concentrations of ethanol as a substrate. ADH activity was
measured using liver extract at pH 7.4 by monitoring the production of NADH
with a fluorescence spectrophotometer. The liver ADH activity of Adh1−/−mice
was also measured in the presence of 1.38 M tert-butanol as a hydrophobic
substance (–♦–).
Fig. 2. Effect of Adh3 null mutation on LORR following the administration of
various doses of ethanol. The sensitivity was evaluated by measuring the
duration of LORR following the administration of ethanol at doses of 3.0, 4.0
and 4.5 g/kg (n=5 for each dose). LORR was significantly longer in Adh3−/−
(–●–) than in WT mice (–○–) (Pb0.005 by ANOVA).
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activity of Adh1−/− mice was very small at the concentrations of
ethanol found in the blood due to a deficiency in ADH1, it was
greatly enhanced in the presence of the hydrophobic solvent
tert-butanol (1.38M) (Fig. 4).
3.4. Effects of solution hydrophobicity on ethanol oxidation
activity of ADH3
Table 1 shows the effects of hydrophobic substances on the
ethanol oxidation kinetics of purified mouse ADH3. Tert-
butanol and three kinds of fatty acid amides greatly increased
the catalytic efficiency (kcat/Km) of ADH3 depending on their
concentration by markedly reducing Km. Tert-butanol activated
ADH3 the most among the four substances without acting as a
substrate for ADH. Fatty acid amides (C4–C6) increased theFig. 3. Zymograms of ADH isozymes in the liver and stomach of Adh3−/−,
Adh1−/– and WT mice. Tissue extracts were subjected to 7.5% acrylamide gel
electrophoresis at pH 9.7. ADH activity was detected by neotetrazolium/PMS
staining at pH 10.7, using 7 mM hexenol as a substrate [34]. A, Adh3−/−; B,
Adh1−/−; C, WT mice.maximum catalytic efficiency of ADH3, depending on their
hydrophobicity.
3.5. Cytoplasmic solution hydrophobicity of liver cells
Fig. 5a shows a fluorescence microscope image of mouse
liver tissue stained with Nile red, which acts as a fluorescent
probe for hydrophobicity. Lipid droplets (L) in the tissue
emitted yellow-gold fluorescence, while liver cells showed a
diffuse general staining of the cytoplasm with red-shifted
fluorescence. The background (B) of the tissue and the nucleus
of the cells (N) were almost black due to the lack of
fluorescence. Spectrograms of the emission fluorescence from
lipid droplets and liver cells in the same sample are shown in
Fig. 5b, together with that from the cell membranes of red-cellTable 1
Effects of hydrophobic substances on ethanol oxidation kinetics of mouse Class
III ADH (ADH3)
Hydrophobic
substances
Conc. (M) Km (M) kcat
(min−1)
kcat/Km
(M−1 min−1)
Non NS a 6.2 b
tert-Butanol (C4) 0.12 3.88 37.9 9.8
0.46 2.24 42.1 18.8
1.38 0.31 19.4 62.6
Butyramide (C4) 0.10 3.17 26.1 8.2
1.00 1.66 22.3 13.4
Valeramide (C5) 0.05 2.92 25.1 8.6
0.50 1.61 24.4 15.2
Capronamide (C6) 0.10 2.38 44.6 18.7
0.20 0.27 8.6 31.9
Activity of purified ADH3 was measured with ethanol as a substrate in the
presence of a hydrophobic substance in 0.1 M Na, K phosphate buffer (pH 7.4)
at 37 °C.
a NS: Not saturable up to 3 M.
b Estimate based on the slope of the curve of velocity vs. substrate
concentration {v=(kcat/Km)[E][S]}.
Fig. 5. Evaluation of cytoplasmic solution hydrophobicity of mouse liver by Nile red staining. A liver slice (ca. 60 μm thick) of a WT mouse (9 weeks old) was
mounted on a micro slide glass and stained with Nile red as a hydrophobic, fluorescent probe. (a) Nile red fluorescence of mouse liver tissue observed with a
fluorescence microscope at excitation wavelengths of 400–440 nm and emission wavelengths of 480–700 nm. B: Background of PBS, L: Lipid droplets. Scale bar, 40
μm. (b) Nile red fluorescence spectra of liver cells ( ) and lipid droplets ( ) in liver tissue, and cell membranes of mouse red-cell ghosts (- - - -). Unstained
liver cells ( ). (c) Confocal laser scanning microscope image of Nile red fluorescence of a mouse liver cell. The emission fluorescence was selected with a band
pass filter (N640 nm). B: Background of PBS, N: Nucleus of liver cell. Scale bar, 5 μm.
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(red shift), unlike those of lipid droplets and cell membranes.
Fig. 5c shows an image of liver cells observed with a confocal
laser scanning microscope (CLSM) with a band-pass filter for
wavelengths above 640 nm. As indicated by the red color, the
cytoplasm of the liver cell almost uniformly emitted a Nile red
fluorescent signal above 640 nm with higher intensities than the
background of PBS, indicating that the cytoplasmic solution of
liver cells is diffusely hydrophobic. The elevated hydrophobic-
ity of liver cytoplasm relative to non-cellular media suggests
that ADH3 ethanol activity is significantly higher in intact cells
than in a cell-free assay.
4. Discussion
Although the ADH1-independent pathway is known to play
a significant role in systematic ethanol metabolism in mammals,
the enzyme responsible for the pathway has not been identified
in spite of three decades of effort. However, the present study
using Adh3-null mice revealed that ADH3 accounts for the
pathway for the state of acute alcohol intoxication, because the β
value was significantly lower for Adh3−/− mice than for WT
mice at ethanol doses of 3 g/kg and more (Fig. 1). Judging from
the data showing that the differences in the β value between the
two genotypes increased as the ethanol dose increased (Fig. 1),
ADH3 contributes dose-dependently to systemic ethanol
metabolism, and keeps the rate of ethanol metabolism constant,
irrespective of the ethanol dose. No difference in the β values
between the two genotypes observed at a dose of 2 g/kg (Fig. 1)
implies that ADH3 has little contribution to systemic ethanol
metabolism for the state resulting from ordinary drinking. On
the other hand, the contribution of ADH1 to systemic ethanolmetabolism decreases dose-dependently, as shown by the
marked dose-dependent decrease in the β value of Adh3−/−
mice, whose ethanol metabolism depends mostly on ADH1.
This is supported by a dose-dependent decrease in the liver
ADH1 content [8] and by the substrate inhibition of ADH1 by
the formation of dead-end ADH–NADH–ethanol complex at
higher concentrations [38]. The substrate inhibition of ADH1 is
reflected in the concentration-dependent decrease in the liver
ADH activity of Adh3−/− mice, which was observed at ethanol
concentrations above 15 mM (Fig. 4).
The effect of first-pass metabolism (FPM) by gastric ADH3,
which has been recently suggested by Lee et al. [30], is probably
not involved in the results obtained in the this study, because
ethanol was administered to mice intraperitoneally (not orally),
and at doses of 2 g/kg and more, at which the effect of FPM is
not observed on the level of blood ethanol [39].
Thus, ADH3 was demonstrated to play a major metabolic
role during acute alcohol intoxication by compensating for the
reduced contribution of ADH1. ADH3 may also play an
important role in the alcohol metabolism of alcoholics with liver
disease, because ADH3 activity in the liver increases as a
patient's alcohol intake increases [28], in spite of a decrease not
only in the ADH1 activity [7,28] but also in the MEOS [40] and
catalase [41] activity in the liver. In addition, ADH3, which is a
ubiquitous ADH and the earliest one to appear in vertebrate
animals [21], is probably the evolutionary origin of the alcohol-
metabolizing enzymes in mammalian cells.
As shown by the LORR data in Fig. 2, the depressant effect
of ethanol on the CNS is stronger in Adh3−/− than in WT mice,
probably due not only to the delay of systemic ethanol
metabolism in Adh3−/− mice, but also to the lack of ADH-
dependent ethanol metabolism in the brain because Adh3−/−
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the other hand, the stronger depressant effect found in Adh1−/−
mice (Results) may simply be due to a marked delay of ethanol
metabolism (Fig. 1). Thus, not only ADH1 but also ADH3 was
found to have a protective role in acute alcohol intoxication.
The finding that ADH3 participates in alcohol metabolism in
vivo is seemingly inconsistent with the low level of activity of
this ADH toward ethanol in vitro at the concentrations present
in blood, which is reflected in the liver ADH activity of Adh1−/−
mice (Fig. 4). This seeming discrepancy between in vivo and in
vitro results is discussed below.
The low level of ADH3 activity toward ethanol is
attributable to the markedly greater volume of its substrate-
binding pocket than that of ADH1 due to the substitution of
smaller, more hydrophilic residues [43]. However, Moulis et al.
[26] and Engeland et al. [44] have suggested that the binding of
an anionic hydrophobic ligand (e.g., fatty acid) to Arg-115 of
human ADH3 can potentiate the oxidation of ethanol due to
structural changes in the binding pocket. We also examined the
effects of various hydrophobic substances (19 substances
including physiological ones) on the ethanol oxidation activity
of purified mouse ADH3 and found that they all enhance the
ADH3 activity, regardless of possessing no anion [27] (Table 1).
As shown in Table 1, hydrophobic substances with no anion
markedly increased the catalytic efficiency (kcat/Km) of ADH3
in ethanol oxidation due to a marked decrease in Km. We found
that tert-butanol activated ADH3 ethanol oxidation almost
tenfold without acting as a substrate—the most among various
hydrophobic substances (Table 1) [27]. Tert-butanol (C4),
which is known to strongly induce solution hydrophobicity in a
medium due to its strong hydrophobic hydration and its
miscibility, irrespective of the concentration, because of the
quadrilateral structure of its molecule [45]. Fatty acid amides
also activated ADH3, depending on the lengths of their carbon
chain (C4–C6) (Table 1), though their degrees of activation
were smaller than those of corresponding fatty acids with an
anion (data not shown). These results indicate that the oxidation
of ethanol by ADH3 is activated by solution hydrophobicity
itself, regardless of what induces it. The liver ADH activity of
Adh1−/− mice was also activated by solution hydrophobicity
induced by tert-butanol (Fig. 4), reflecting an effect on the
ethanol oxidation activity of ADH3, an only ADH activated by
tert-butanol.
We observed no significant changes in the secondary, tertiary
or quaternary structures of mouse ADH in hydrophobic
solutions (data not shown), therefore, we concluded that
solution hydrophobicity induces a slight structural change in
the substrate-binding pocket of this ADH3. The hydrophilic
amino acids constituting the pocket of ADH3 collapse in a
hydrophobic medium, thus reducing the pocket size. Such a
structural change in the pocket of ADH3 may raise its affinity
for a small molecule like ethanol and thereby increase the
ethanol oxidation activity of ADH3. Ebina et al. also [46]
reported the effects of hydrophobic substances on the activity of
chymotrypsin, and concluded that hydrophobic substances alter
hydrophobic interactions within an enzyme protein to change
the structure of the active center.Nile red is strongly fluorescent only in a hydrophobic
environment; it fluoresces yellow-gold in lipids and hydro-
carbon solvents and does not interact with any tissue
constituent except in solution [35]. In an aqueous medium
of hydrophobic substances with a polarity such as that of
ethanol or phosphatidylcholine vesicles, its fluorescence peak
is red-shifted up to 665 nm and quenched, depending on the
water content [47]. A cytoplasmic solution of liver cells seems
to be in a diffuse hydrophobic state, because the cytoplasm is
almost uniformly stained by Nile red and exhibits red-shifted
fluorescence, in contrast to the unstained bulk water of PBS
(Fig. 5a, c). The diffuse staining of cytoplasm accompanied by
the red-shifted fluorescence of Nile red has also been reported
for other types of cells [35]. Measurement of the water
diffusion coefficient of the cell by NMR also have
demonstrated that intracellular water molecules are dynami-
cally restrained by a hydrophobic interaction with various
macromolecules and intracellular membranes with an exten-
sive reticulum [48]. Therefore, the in vivo contribution of
ADH3 to alcohol metabolism is likely to involve the
activation of ADH3 by cytoplasmic solution hydrophobicity,
as shown here in vitro (Table 1). Allue et al. [49] reported
that, in vitro, the luciferase Km for ATP in a high-protein
milieu shifts markedly to a value similar to that for the
enzyme in the cytoplasm of mammalian cells. Thus, some
kinds of enzyme activity in a cell could be very different from
the activity measured in vitro due to a marked difference in
solution conditions between the two milieus. Recent studies
on Adh3−/− mice have revealed that ADH3 contributes to
systemic retinol metabolism in spite of its extremely low
retinol oxidation activity in vitro: it is lower than 0.1% of that
observed for ADH1, the key enzyme in systemic retinol
metabolism [25].
In conclusion, Adh3-null mice were used to demonstrate
that, in spite of its poor ethanol oxidation activity in vitro,
ADH3 plays an important role in systemic ethanol metabolism
at higher levels of blood ethanol, likely being activated by
cytoplasmic solution hydrophobicity, and leads to a diminution
of acute ethanol intoxication.
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